Buspirone improves symptoms in functional dyspepsia

Buspirone improves symptoms in functional dyspepsia
Buspirone, a 5-hydroxytryptamine 1A receptor agonist, improves symptom severity in patients with functional dyspepsia, according to a proof-of-concept study published in the November issue of Clinical Gastroenterology and Hepatology.

(HealthDay)—Buspirone, a 5-hydroxytryptamine 1A receptor agonist, improves symptom severity in patients with functional dyspepsia (FD), according to a proof-of-concept study published in the November issue of Clinical Gastroenterology and Hepatology.

Jan Tack, M.D., Ph.D., from the University of Leuven in Belgium, and colleagues conducted a crossover study involving 17 patients (13 women; mean age, 38.5 years) to examine the effects of buspirone on the symptoms and mechanisms of FD. In the first of two treatment periods, seven participants were randomized to receive buspirone (10 mg, three times daily for four weeks) and 10 were given 15 minutes before meals. Following a two-week washout period, patients switched groups for the second period.

The researchers found that buspirone correlated with a significant reduction in the overall severity of symptoms of dyspepsia and individual symptoms of postprandial fullness, early satiation, and upper abdominal bloating, compared to the placebo, which had no significant effect. Buspirone significantly increased gastric accommodation, compared with placebo, and delayed gastric emptying of liquids, but did not alter the rate of gastric emptying of solids or sensitivity to gastric distention. Adverse events were similar when patients received buspirone or placebo.

"In patients with FD, four weeks of administration of buspirone significantly improved symptoms and gastric accommodation, compared with placebo, whereas gastric emptying of liquids was delayed," the authors write.

More information: Abstract
Full Text

Related Stories

In diabetes, gastric emptying remains stable over time

date Aug 24, 2012

(HealthDay)—Gastric emptying of solids and liquids and gastrointestinal symptoms remain stable over time in patients with long-term type 1 and type 2 diabetes, according to a study published online Aug. ...

A potential treatment for gastric motility disorders

date Jun 10, 2009

GES or pacing has been under investigation as a potential therapy for gastrointestinal motility disorders. Conventionally, GES is performed using a single pair of electrodes or single-channel GES. However, few studies have ...

Recommended for you

Niger battles deadly meningitis epidemic

date 37 minutes ago

Parents cradling sick children in their arms streamed into a treatment centre in Niger's capital Niamey, the victims of a meningitis epidemic that has claimed over 100 lives and appears to be accelerating.

Long lasting anti-hemophilia factor safe in kids

date 5 hours ago

Children with hemophilia A require three to four infusions each week to prevent bleeding episodes, chronic pain and joint damage. The effect on quality of life can be significant, due to time and discomfort associated with ...

Missouri detective battles flesh-eating infection

date 9 hours ago

Friends and loved ones of Lee's Summit, Mo., Police Detective Joshua Ward are praying for the 34-year-old married father of three who, even after five surgeries in as many days, remained in critical condition Monday at St. ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.